Global Nasal Spray Market is Expected to Register a Healthy CAGR in the Forecast Period of 2019 to 2026


Global Nasal Spray Market

Nasal spray is usually used as a medication whenever there is any congestion in the nose or any other allergies. It usually reduces swelling and congestion by widening the blood vessels. They are used to treat conditions such as common cold, allergies, hay fever, sinusitis and other. Different types of the nasal spray are saline nasal spray, steroid nasal spray, and others. There main function is to provide comfort to the nasal. Increasing demand for self-administrative drug delivery is the actor fueling the market growth.

Access Full Report at

Segmentation: Global Nasal Spray Market

Recent Developments

  • In April 2017, Sandoz Canada in Boucherville, Quebec launched in Mosaspray (Mometasone Furoate Monohydrate) nasal spray. It is a nasal spray for the treatment of the perennial allergic rhinitis for people of 12 years of age or older.
  • In May 2017, C.G. Papaloisou Ltd (Cyprus), introduced Dymista nasal spray which is used to relief symptoms of allergic rhinitis caused by seasonal changes, only if when monotherapy with glucocorticoid and antihistamine is not sufficient. Dymista product is a combination of azelastine hydrochloride (antihistamine) and fluticasone propionate (glucocorticoid) and is manufactured by Meda AB (Sweden).
  • In February 2016, Nemera, launched a prescription drug named Advancia in the Europe market. Advancia nasal spray is used in an intranasal corticosteroid suspension to treat allergic rhinitis. Advancia comes in a user friendly pack that has a user-independent device which is ideal for topical and systemic preserved drugs.

Key Market Competitors:

Some of the prominent participants operating in this market are ADAPT Pharma, Inc., Sandoz International GmbH, INNOVUS PHARMACEUTICALS, INC., Cipla Inc., Aurena, J Pharmaceuticals, Bayer AG, St. Renatus, ARIUS FORMULATIONS PVT LTD, Ultratech India Limited, GlaxoSmithKline plc, Egalet Corporation, LEEFORD HEALTHCARE LTD, Aishwarya Group, Mylan N.V., Pfizer Inc., Teva Pharmaceutical Industries Ltd., Catalent, Inc and ALLERGAN among others.

Browse Related Report:

Global Nasal Drug Delivery Market- Dosage Form (Nasal Spray, Nasal Drops And Liquids, Nasal Gels, Nasal Powders And Others), Container (Non-Pressurized Containers, Pressurized Containers), End- User (Hospitals, Home Care Settings), Geography (North America, South America, Europe, Asia-Pacific, Middle East And Africa)- Industry Trends and Forecast to 2025

Global Ear and Nasal Packing Market By Type (Nasal (Injectable, Gel, Dressings (Sponges, Splints, Strips)), Ear (Injectable, Gel, Dressings (Sponges, Splints, Strips))), Material (Bioresorbable (Chitosan, HYAFF, Combination), Non-Absorbable (CMC, Synthetic, Others)), Distribution Channel (Direct Tender, OTC), End-User (Hospitals, Clinics, Ambulatory Centers), Geography (North America, Europe, APAC, South America, Middle East and Africa)  – Industry Trends & Forecast to 2026